Systematic review / meta-analysis / 2013
Coffee consumption was linked to a lower risk of hepatocellular carcinoma.
A meta-analysis of 16 observational studies (8 case-control and 8 cohort) evaluated coffee intake and hepatocellular carcinoma (HCC) risk. Any coffee consumption versus none was associated with an RR of 0.60 (95% CI, 0.50-0.71), while summary RRs were 0.72 (95% CI, 0.61-0.84) for low consumption, 0.44 (95% CI, 0.39-0.50) for high consumption, and 0.80 (95% CI, 0.77-0.84) for an increment of 1 cup per day. The inverse association was consistent across sex, alcohol intake, and history of hepatitis or liver disease, though authors noted the link might partly or largely exist because patients with liver and digestive diseases reduce their coffee intake.
Shows an association, not proof of cause and effect.
- Study type
- Meta-analysis of case-control and cohort studies
- Who was studied
- 16 studies comprising 3,153 hepatocellular carcinoma cases
- What was measured
- Hepatocellular carcinoma (HCC) risk
THE PAPER
Coffee reduces risk for hepatocellular carcinoma: an updated meta-analysis.
Bravi F, Bosetti C, Tavani A, Gallus S, La Vecchia C. Clin Gastroenterol Hepatol, 2013.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.